Optimizing a therapy for opiate use disorders: Characterizing ondansetron pharmacokinetics in blood and brain
Abstract Administration of a widely used 5‐hydroxytryptamine receptor (5HT3AR) antagonist (ondansetron) potently inhibited the development of experimentally induced opioid dependence and withdrawal responses in mice and humans. However, in several studies examining withdrawal symptoms in subjects wi...
Shranjeno v:
Main Authors: | , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Wiley,
2023-02-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!